Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Takeda commences new growth plan

Takeda commences new growth plan

14th May 2010

Takeda has initiated a new business transformation plan which will underpin its growth and innovation objectives up to 2012.

The company has embarked on its 2010-2012 Mid-Range Plan a year ahead of schedule due to the changing and challenging nature of the market and is now aiming to achieve annual net sales of 1.3 billion yen (9.9 million pounds) in 2012.

Among its product development targets for the next two years are an increased focus on the core therapeutic areas of metabolic and cardiovascular illness, oncology and central nervous system diseases.

It will also be looking to improve the productivity of its research and development activities and expand into new regions.

The firm said: “In this way, the company will work to realise its corporate mission of striving towards better health for patients worldwide through leading innovation in medicine.”

Earlier this week, the company published its financial report for the fiscal year ending March 31st 2010, during which its sales takings declined due in part to unfavourable exchange rate fluctuations.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.